 |

home
Syllabus
Glossary
Gallery
1a: History
1b: Guidelines
1c: Epidemiology
1d: Structure
1e: Circulation
Lesson 1 REVIEW
2a: Anomalies
2b: Dextrocardia
2c: Coronary Arteries
2d: Indicators of Function
Lesson 2 REVIEW
3a: Electrophysiology
3b: Conduction
3c: Action Potential
3d: Autonomic System
Lesson 3 REVIEW
4a: Electrocardiography
4b: EKG Slideshow
4c: EKG Interpretation
4d: Myocardial Damage
Lesson 4 REVIEW
5a: Cardiovascular Disease
5b: Coronary Syndromes
5c: Atherosclerosis
5d: Myocardial Infarction
5e: Cardiac Stress Testing
5f: Cardiac Medications
5g: Revascularization
Lesson 5 REVIEW
6a: Diagnostic Imaging
6b: Radiopharmaceuticals
6c: Thallium Scintigraphy
6d: Tc99m MPI Agents
6e: PET Imaging
6f: Blood Pool Imaging
6g: Cardiac Function
Lesson 6 REVIEW
7a: Planar Cardiac Imaging
7b: Cardiac SPECT Imaging
7c: Cardiac SPECT Anatomy
7d: Interpretation
7e: Attenuation Correction
Lesson 7 REVIEW
Gallery
|
 |
LESSON 6f page 4
CARDIAC BLOOD POOL IMAGING
GATED TOMOGRAPHIC RADIONUCLIDE ANGIOGRAPHY (SPECT MUGA)
It has recently become possible to combine gated blood pool imaging with photon emission computed tomography (SPECT). It allows the automated identification of the left
ventricular surface in gated tomographic radionuclide ventriculograms. Data can be displayed in three dimensions. It has been shown that the regurgitation fraction in patients with mitral and aortic insufficiency is accurately measured
by gated radionuclide angiography SPECT imaging. Although the resolution of gated SPECT is not as high as magnetic resonance imaging, it is relatively
inexpensive and provides an accurate picture of ventricular function.
FORMULATION PROBLEMS WITH TAGGED RBC'S
|
FORMULATION PROBLEM |
CLINICAL MANIFESTATION |
|
Carrier 99Tc (especially with AC) |
labeling efficiency; free pertechnetate |
|
|
Al3+ |
RBC agglutination
|
|
|
Very acidic pH |
RBC hemolysis |
|
|
Inadequate stannous |
free pertechnetate |
|
|
Excessive stannous |
plasma activity, spleen uptake
|
|
Excessive 99mTc activity added |
rate and extent of labeling
|
|
|
Improper mixing order |
liver uptake; labeling efficiency
|
|
|
Low cell concentration |
rate and extent of labeling |
|
|
Radiolytic decomposition and/or oxidation |
free pertechnetate |
|
|
Inadequate incubation time |
free pertechnetate |
|
|
Incubation at < 37 C |
rate of labeling; free pertechnetate |
|
|
Heparin vs ACD |
labeling efficiency; extravascular activity; urinary excretion |
|
|
ACD vs heparin |
stability; blood/background ratio |
|
|
EDTA as the anticoagulant |
labeling efficiency |
|
|
Excess ACD |
sequestration in spleen; labeling efficiency |
|
|
Large volume of pertechnetate solution |
rate and extent of labeling |
|
|
Inadequate volume of blood |
labeling efficiency |
|
|
EDTA as a sequesterant |
blood pool retention; splenic accumulation
|
|
| |
|
|
DRUG INTERFERENCE
Agents that alter, by direct pharmacological effect, cardiac function and have the potential to interfere with interpretation of the gated blood pool study:
- beta blockers (propranolol, 48 hr)
- calcium channel blockers (verapamil, 48-72 hrs)
- nitrates (nitroglycerin, 12 hr)
REASONS FOR ERROR IN EJECTION FRACTION DETERMINATION
OVERESTIMATION OF EF VALUES
Background ROI placed too close to or over activity in spleen or descending aorta
ROI too large (but does not include LA)
Patients with postero-basal aneurysm
UNDERESTIMATION OF EF VALUES
Inclusion of LA in left ventricular ROI, particularly at end diastole
Poor separation of left and right ventricles
Using a fixed ROI
End-systolic ROI too large
Inclusion of ascending aorta in end-diastolic ROI
Placement of background ROI over photopenic area
ECG gating problems
Poor definition of true end-systolic volume (inadequate temporal resolution)
Patients with antero-apical aneurysm or markedly enlarged LV
|
MUGA TROUBLE SHOOTING |
|
Problem
|
Possible Causes
|
Remedies
|
|
Blurry Study
low counts
poor target to
background
|
dose infiltrated
very obese
patient
off peak
bad lot of
Pyrophosphate
heparin or other
drug |
reinject 5 mCi
Tc-99m or re-peak
send vials to
drug company
redo with labeled
HSA
|
Not gating
well missing beats |
R wave too low |
Switch leads to
find highest R wave |
|
Not gating well
atrial fibrillation
|
wide variability
R-R’s |
widen beat acceptance window |
|
Not gating well
atrial,
ventricular arrhythmias |
wide variability
R-R’s |
Patience
If persistent
biventricular bigeminy, reschedule patient
|
|
Not gating well
paced rhythm
|
dual chamber;
gating on atrial and ventricular artifacts |
Call EP group to
put magnet on pacemaker to change VVI |
|
Big hot spleen
|
malignancy |
In the lateral
view make sure the heart is in FOV |
|
Heart not beating
in lateral view |
ECG lead off |
put lead back on
and repeat view |
|
Complex cardiac
anatomy and difficulty finding best septal angle |
complex CHF marked dilation of one chamber |
Ask MD for
assistance
Take ANT or LAT
No zoom for
anatomy |
|
Poor gating
during first stages exercise |
poor lead contact |
Stop exercise,
replace all leads and electrodes, have patient exercise briefly to
make sure signal stable before restarting. Drop of normal saline on skin under
electrode. |
|
In 3 view MUGA
one image looks “asystolic” |
Lost gate or ECG
lead |
Repeat that view |
| |
|
|
|
|
 |